Maintaining vitamin D levels in your youth can help protect your brain from early dementia

The main result of the study was the identification of an inverse correlation between the concentration of vitamin D at middle age and the accumulation of tau protein in brain tissues later on. Tau protein is one of the key pathological markers of neurodegeneration, and its excessive deposition in neurons leads to impaired neuronal function and subsequent cell death. High levels of circulating vitamin D were associated with a lower overall burden of tau protein, particularly in the brain regions that are the first to be affected in Alzheimer’s disease.

Interestingly, no similar association was found with the deposition of amyloid plaques, another important feature of the disease. The authors of the study suggest that this may be due to the fact that tau pathology begins to form in the preclinical stages earlier or responds more specifically to metabolic factors at a younger age. Notably, the presence of a genetic risk factor (the APOE ε4 genotype) did not alter the observed association.

The protective effect of vitamin D is due to the presence of specific receptors for this compound in the hippocampus and other brain regions responsible for cognitive functions. Vitamin D in the form of calcitriol performs a number of critical functions in the central nervous system:

• Regulation of inflammation: reduces the production of pro-inflammatory cytokines and activates antioxidant enzymes such as superoxide dismutase and glutathione peroxidase;
• Phosphorylation control: normalizes enzyme activity, preventing hyperphosphorylation of tau protein, which leads to its aggregation;
• Support for neurotrophic factors: stimulates signaling pathways necessary for neuronal survival and adaptation.

Data analysis also indicated a possible dose-response relationship. Participants in the top 10-20% of vitamin D concentration levels showed the most significant reduction in tau protein accumulation compared to other groups. In contrast, vitamin D deficiency was correlated with increased neuroinflammation and reduced brain antioxidant protection.

Despite the significance of the findings, the authors acknowledge several limitations. The majority of the study participants were of European descent, which requires caution when extrapolating the findings to other ethnic groups. Additionally, the participants’ lifestyle and diet may have changed significantly over the 16-year follow-up period, which was not accounted for in the single measurement of vitamin D levels.

Nevertheless, the study confirms that middle age is a critical “window of opportunity” for risk factor correction. Maintaining an adequate level of vitamin D in the 30s and 40s can be an effective strategy for primary prevention of neurodegenerative diseases long before the first clinical symptoms appear.